Catechol, vitamin C and DMF (US FDA-approved Nrf2 activator to treat relapsing forms of multiple sclerosis) reduced the NNKAc-induced ROS levels in BEAS-2B cells at 25 and/or 50 μM. The gene discussed is NFE2L2; the disease is multiple sclerosis.